Navigation Links
AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting

Results showed an overall CBR of 52% which compares favorably with the activity of mTOR inhibitors

QUEBEC CITY, QC, June 04, 2007 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. , a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner, Keryx Biopharmaceuticals presented a poster outlining Phase 1 and Phase 2 results for perifosine, an oral anti-cancer signal transduction inhibitor compound, for the treatment of patients with advanced sarcoma. Results of the Phase 1 and Phase 2 studies of perifosine showed an overall clinical benefit rate (CBR) of 52% which compares favorably with the activity of mTOR inhibitors. The poster titled, "Perifosine (P) an active agent in the treatment of patients with advanced sarcoma": R. Birch, S. Chawla, J. Nemunaitis, P. Savage, P. Kaiser, A. Spira, A. Cervera, E. Middleman, E. Sausville, M. Knowling, I. Henderson, was presented Sunday, June 3, 2007 at the American Society of Clinical Oncology's (ASCO) Annual Meeting currently being held in Chicago, Illinois.

David J. Mazzo, Ph.D., President and CEO of AEterna Zentaris commented, "We are very encouraged by the data from these Phase 1 and Phase 2 trials confirming single agent activity with perifosine in patients with advanced sarcomas, comparable to the activity of mTOR inhibitors."

Background

Perifosine is a novel oral alkylphospholipid that targets the PI3K pathway upstream from mTOR by inhibiting the phosphorylation of Akt. Perifosine's activity against sarcomas has now been evaluated in 145 patients enrolled in one of three Phase 1 trials or four Phase 2 trials. Five of these trials have been published.

    Methods


    Dose categories were as follows:


    -------------------------------------------------------------------------

    Lower Dose                           Higher Dose

    ----------------------------------------------------
'"/>




Page: 1 2 3 4

Related medicine technology :

1. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
2. AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los Angeles
3. AEterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
4. AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
5. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
6. terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. GenoLogics Announces Bioinformatics Partnership with Illumina
9. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
10. Inovio Biomedicals Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
11. Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Companys Investigational Drug to Treat Cocaine and Methamphetamine Addiction
Post Your Comments:
(Date:3/27/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... trauma patients. Available in both small (6mm) ... External Fixation System from Zimmer is a modular system that ... The XtraFix System allows surgeons to eliminate steps, ... process, resulting in saved time, costs and overall team effort. ...
(Date:3/27/2015)... According to a new market research report ... Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, ... Global Forecasts to 2019 ", published by MarketsandMarkets, the Electrophysiology ... by 2019 with a CAGR of around 10.3% during ... Browse   90   ma rket data T ...
(Date:3/27/2015)... -- Johnson & Johnson (NYSE: JNJ ) will webcast its ... Thursday, April 23, 2015, from the State Theatre in ... other interested parties may access the live audio webcast of ... and clicking on the webcast icon. A ... a few hours after the live meeting concludes.  The webcast ...
Breaking Medicine Technology:Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4
... largest single market growth opportunity in global nutrition.  Abbott expects ... $1 billion (USD) by the end of 2014. China also continues ... In the first half of the year, more than 26 ... nearly 42 percent of Abbott Nutrition,s global sales were in ...
... Aug. 16, 2011 Accuray Incorporated ... announced today that the Beth Israel Deaconess Medical Center ... a leader in pioneering innovative technology to advance patient care, ... Robotic Radiosurgery System. The first center in New England to ...
Cached Medicine Technology:Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market 2Beth Israel Deaconess Medical Center Treats 2,000th Patient with the CyberKnife System 2Beth Israel Deaconess Medical Center Treats 2,000th Patient with the CyberKnife System 3Beth Israel Deaconess Medical Center Treats 2,000th Patient with the CyberKnife System 4
(Date:3/28/2015)... March 28, 2015 Coffee could not only ... protect you from gum disease, researchers have found. , They ... disease. , Coffee contains antioxidants. Antioxidants fight gum disease. Does ... researchers at Boston Univ. Henry M. Goldman School of Dental ... August 2014 issue of the Journal of Periodontology. , “This ...
(Date:3/28/2015)... 28, 2015 Thousands of transvaginal ... by C.R. Bard, Inc. continue to move forward ... Court, Southern District of West Virginia, where Bernstein ... the Plaintiffs’ Steering Committee. According to an ... certain defendants named in those lawsuits leave to ...
(Date:3/28/2015)... Centurion Service Group will be hosting a live on-site and ... Las Vegas warehouse, located at 4606 Andrews St. Suite 3, ... equipment from hospitals and surgery centers from around the United ... Buyers will find items of all types including anesthesia, endoscopy, ... Erik Tivin, CEO of Centurion. , Among the sale’s ...
(Date:3/28/2015)... Early surgery may not be the best ... injuries, according to new research from Tripler Army Medical ... Society for Sports Medicine’s ( AOSSM ) Specialty Day, ... was not performed. , The final study group focused ... 17 receiving non-surgical therapy. Of the non-surgery group, 8 ...
(Date:3/28/2015)... 2015 Healthpointe’s otolaryngologists, medical practitioners who ... disorders, are now offering a wide variety of ... is characterized by the presence of phantom sounds or ... tinnitus is a prevalent symptom that can arise due ... non-fatal, tinnitus can impede a person’s quality of life. ...
Breaking Medicine News(10 mins):Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2
... SEGUNDO, Calif., Dec. 27 Computer Sciences,Corporation ... it has signed an extension to,a global ... Sun Microsystems Inc., Under the five-year ... development and support services for Sun,s business,applications ...
... Women Urged to Take Action and Protect Themselves in ... Approximately,10,000 American women will learn they have cervical cancer/HPV ... form of the disease. This,January, during Cervical Health Awareness ... educating women about the importance,of the Pap test as ...
... Goal: Increase Testing While Preserving Choice, SACRAMENTO, ... operator of the largest non-government HIV testing,program in ... new HIV,testing protocol signed into law yesterday in ... legislation requires the routine testing of pregnant,women and ...
... supply tumors slows the progression of metastatic breast ... trial of Avastin, an anti-angiogenic therapy. The study, ... New England Journal of Medicine, found that Avastin ... for women with breast cancer compared to chemotherapy ...
... First, prescribed to protect the heart, can lead to ... 26 (HealthDay News) -- Men undergoing hormone therapy for ... heart run a significantly higher risk of dying, new ... hormone therapy to elevate liver-function test levels. The end ...
... Health,Services, Inc. (Nasdaq: GTIV ), the nation,s leading ... that it is,scheduled to present from 1:30 p.m. to ... Annual JPMorgan Healthcare Conference in San Francisco., The ... live audio web cast,which may be accessed by visiting ...
Cached Medicine News:Health News:CSC Signs Extension to Managed Applications Services Agreement With Sun Microsystems 2Health News:National Cervical Cancer Coalition Stresses Importance of Screening and Prevention During January Cervical Health Awareness Month 2Health News:AHF Says 'Op-Out' Clause is Crucial to New Jersey Law Requiring HIV Testing of Pregnant Women 2Health News:AHF Says 'Op-Out' Clause is Crucial to New Jersey Law Requiring HIV Testing of Pregnant Women 3Health News:Bevacizumab found to improve survival for patients with advanced breast cancer 2Health News:Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients 2Health News:Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients 3Health News:Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco 2Health News:Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco 3
...
...
Rev. Angled 9.5 overall length 4.5 handle 240 mm....
Temporary...
Medicine Products: